Literature DB >> 8554078

Choroidal capillary and venous congestion in central serous chorioretinopathy.

C Prünte1, J Flammer.   

Abstract

PURPOSE: Abnormalities in choroidal perfusion have been hypothesized to be causative factors in central serous chorioretinopathy. This prospective study was performed to evaluate changes in the choroidal circulation in cases of central serous chorioretinopathy.
METHODS: In 32 consecutive patients with acute or chronic recurrent central serous chorioretinopathy, complete clinical ophthalmologic examinations, fluorescein angiography, and indocyanine green angiography with a scanning laser ophthalmoscope and a digital imaging system were performed.
RESULTS: All patients with acute and chronic recurrent central serous chorioretinopathy demonstrated a localized delay in arterial filling followed by choroidal hyperperfusion in the area of the damaged retinal pigment epithelium, frequently associated with dilated capillaries and dilated draining venules in one or more choroidal lobules. These changes corresponded to areas with pigment epithelial detachment or focal leakage from the retinal pigment epithelium found in fluorescein angiography. Furthermore, in some patients, localized choroidal ischemia could be observed in additional areas throughout the central fundus in both diseased eyes and normal fellow eyes.
CONCLUSIONS: Delayed arterial filling followed by capillary and venous hyperemia, angiographically appearing as capillary and venous congestion, can be observed frequently in eyes with central serous chorioretinopathy. The results suggested that capillary or venous congestion after ischemia in one or more choroidal lobules might be the reason for the choroidal hyperpermeability associated with central serous chorioretinopathy.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8554078     DOI: 10.1016/s0002-9394(14)70531-8

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  155 in total

1.  [Central serous chorioretinopathy (CSC)].

Authors:  H Baraki; N Feltgen; J Roider; H Hoerauf; C Klatt
Journal:  Ophthalmologe       Date:  2010-05       Impact factor: 1.059

2.  Finasteride for chronic central serous chorioretinopathy.

Authors:  Farzin Forooghian; Annal D Meleth; Catherine Cukras; Emily Y Chew; Wai T Wong; Catherine B Meyerle
Journal:  Retina       Date:  2011-04       Impact factor: 4.256

Review 3.  Central serous chorioretinopathy following oral tadalafil.

Authors:  P Gordon-Bennett; T Rimmer
Journal:  Eye (Lond)       Date:  2011-11-04       Impact factor: 3.775

4.  [Experiences with chronic central serous chorioretinopathy treated with half-dose photodynamic therapy and verteporfin].

Authors:  M Töteberg-Harms; M Kurz-Levin; J Fleischhauer; R Windisch
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

5.  Retinal vascular diameter in young subjects with a vasospastic propensity.

Authors:  Fabrizio Branca; Selim Orgül; Claudia Zawinka; Graziella Reinhard; Josef Flammer
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2005-08-23       Impact factor: 3.117

6.  Morphological changes in the retinal pigment epithelium on spectral-domain OCT in the unaffected eyes with idiopathic central serous chorioretinopathy.

Authors:  Pawan Gupta; Vishali Gupta; M R Dogra; Ramandeep Singh; Amod Gupta
Journal:  Int Ophthalmol       Date:  2009-01-30       Impact factor: 2.031

7.  First and second-order kernel multifocal electroretinography abnormalities in acute central serous chorioretinopathy.

Authors:  Timothy Y Y Lai; Ricky Y K Lai; Jasmine W S Ngai; Wai-Man Chan; Haitao Li; Dennis S C Lam
Journal:  Doc Ophthalmol       Date:  2007-08-29       Impact factor: 2.379

8.  En face enhanced-depth swept-source optical coherence tomography features of chronic central serous chorioretinopathy.

Authors:  Daniela Ferrara; Kathrin J Mohler; Nadia Waheed; Mehreen Adhi; Jonathan J Liu; Ireneusz Grulkowski; Martin F Kraus; Caroline Baumal; Joachim Hornegger; James G Fujimoto; Jay S Duker
Journal:  Ophthalmology       Date:  2013-11-26       Impact factor: 12.079

Review 9.  Retinal Diseases that Can Masquerade as Neurological Causes of Vision Loss.

Authors:  Tanyatuth Padungkiatsagul; Loh-Shan Leung; Heather E Moss
Journal:  Curr Neurol Neurosci Rep       Date:  2020-09-15       Impact factor: 5.081

10.  Central serous chorioretinopathy due to tadalafil use.

Authors:  Fatih Mehmet Türkcü; Harun Yüksel; Alparslan Şahin; Mehmet Murat; Yaşar Bozkurt; Ihsan Çaça
Journal:  Int Ophthalmol       Date:  2012-10-14       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.